Table 1 The characteristics of included studies
Study | Year | Country | Patients(n) | Age(Y) | Study Design | Fracture type | Quality Score | ||
|---|---|---|---|---|---|---|---|---|---|
IMN | PL | IMN | PL | ||||||
Wani IH [13] | 2017 | India | 30 | 30 | 36.4 ± 9.7 | 38.4 ± 8.7 | RCT | OTA42 A1-3 | 5 |
Vallier HA [12] | 2011 | USA | 56 | 48 | 38.1 | 38.5 | RCT | OTA 42 | 6 |
Im GI [15] | 2005 | Korea | 34 | 30 | 42(19,65) | 40(17,60) | RCT | A1-3,C1 | 5 |
Fang JH [18] | 2016 | China | 28 | 28 | 35.0 ± 9.2 | 38.6 ± 7.5 | RCT | OTA 42 | 6 |
Chen G [19] | 2014 | China | 60 | 120 | 53.0 ± 8.1 | 25.53 ± 8.73 | RCT | AO 42A-B | 4 |
Li Y [20] | 2014 | China | 46 | 46 | 44(18-78) | 43(18-79) | RCT | OTA42 | 6 |
Mauffrey C [21] | 2012 | UK | 12 | 12 | 50(39-60) | 33(24-43) | RCT | EAFDT | 6 |
Guo JJ [16] | 2010 | China | 44 | 41 | 44.2(27-70) | 44.4(23-69) | RCT | OTA43A1-3 | 6 |
Costa ML [22] | 2017 | UK | 161 | 160 | 44.3 ± 16.3 | 45.8 ± 16.3 | RCT | EAFDT | 6 |
Polat A [14] | 2015 | Turkey | 10 | 15 | 34.0 ± 9.7 | 36.4 ± 10.7 | RCT | OA42/43A1 | 6 |
Vallier HA [17] | 2012 | USA | 45 | 41 | 41.0 | 37.8 | RCT | OTA42 | 5 |